Corporate Member Update-BeiGene
Corporate Member Update-BeiGene
TEVIMBRA
March, 2025
TEVIMBRA added to NCCN Guidelines for Esophageal and Esophagogastric Junction Cancers and Gastric Cancer.
Objective
To inform Solid Tumor team of recent updates to the National Comprehensive Cancer Network® (NCCN) Clinical Practice Guidelines in Oncology (NCCN Guidelines®) for Esophageal and Esophagogastric Junction Cancers (Version 1.2025) and Gastric Cancer (Version 1.2025).
To read the whole memo, please click here.